Platelet-activating factor-mediated NF-κB dependency of a late anaphylactic reaction

Journal of Experimental Medicine

Volumn 198, Issue 1, 2003, Pages 145-151

  Choi, Il Whan ^a   Kim, Young Suk ^a   Kim, Dae Ki ^a   Choi, Jung Hwa ^b   Seo, Kook Heon ^b   Im, Shun Young ^b   Kwon, Keun Sang ^a   Lee, Myung Shik ^c   Ha, Tai You ^a   Lee, Hern Ku ^a,d  

^a Chonbuk National University Medical School   (South Korea)

^b Chonnam National University   (South Korea)

^c Sungkyunkwan University School of Medicine   (South Korea)

^d University Natl Medical School   (South Korea)

Author keywords

Biphasic anaphylaxis; Early anaphylaxis; Mast cell; Penicillin V; TNF

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; THROMBOCYTE ACTIVATING FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANAPHYLAXIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; IMMUNOMODULATION; IMMUNOPATHOGENESIS; MALE; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSCRIPTION REGULATION;

ANAPHYLAXIS; ANIMALS; HEMATOCRIT; INTERLEUKIN-1; MALE; MAST CELLS; MICE; MICE, INBRED C57BL; NF-KAPPA B; PHOSPHOLIPASES A; PLATELET ACTIVATING FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0038491280     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20022129     Document Type: Article

References (38)

1. Stark, B.J., and T.J. Sullivan. 1986. Biphasic and protracted anaphylaxis. J. Allergy Clin. Immunol. 78:76-83.
2. Sampson, H.A., L. Mendelson, and J.P. Rosen. 1992. Fatal and near-fatal anaphylactic reactions to food in children and adolescents. N. Engl. J. Med. 327:380-384.
3. Douglas, D.M., E. Sukenick, W.P. Andrade, and J.S. Brown. 1994. Biphasic systemic anaphylaxis: an inpatient and outpatient study. J. Allergy Clin. Immunol. 93:977-985.
4. Lee, J.M., and D.S. Greenes. 2000. Biphasic anaphylactic reactions in pediatrics. Pediatrics. 106:762-766.
5. Ishizaka, T., and K. Ishizaka. 1975. Biology of immunoglobulin E. Molecular basis of reaginic hypersensitivity. Prog. Allergy. 19:60-121.
6. Munoz, J., and R.K. Bergman. 1965. Mechanism of anaphylactic death in the mouse. Nature. 205:199-200.
7. Braquet, P., L. Touqui, T.Y. Shen, and B.B. Vargaftig. 1987. Perspectives in platelet-activating factor research. Pharmacol. Rev. 39:97-145.
8. Vilain, B., V. Lagente, C. Touvay, S. Desquand, J. Randon, J. Lefort, P. Braquet, and Vargaftig. 1986. Pharmacological control of the in vivo passive anaphylactic shock by the PAF-acether antagonist compound BN 52021. Pharmacol. Res. Commun. 18(Suppl.):119-126.
9. Hervert, J.M., L. Lespy., and J.P. Maffrand. 1991. Protective effect of SR27417, a novel PAF antagonist, on lethal anaphylactic and endotoxin-induced shock in mice. Eur. J. Pharmacol. 205:271-276.
10. Im, S.Y., S.J. Han, H.M. Ko, J.H. Choi, S.B. Chun, D.G. Lee, T.Y. Ha, and H.K. Lee. 1997. Involvement of nuclear factor-κB in platelet-activating factor-mediated tumor necrosis factor-alpha expression. Eur. J. Immunol. 27:2800-2804.
11. Han, S.J., J.H. Choi, H.M. Ko, H.W. Yang, I.W. Choi, H.K. Lee, O.H. Lee, and S.Y. Im. 1999. Glucocorticoids prevent NF-κB activation by inhibiting the early release of platelet-activating factor in response to lipopolysaccharide. Eur. J. Immunol. 29:1334-1341.
12. Choi, J.H., H.M. Ko, J.W. Kim, H.K. Lee, S.S. Han, S.B. Chun, and S.Y. Im. 2001. Platelet-activating factor-induced early activation of NF-κB plays a crucial role for organ clearance of Candida albicans. J. Immunol. 166:5139-5144.
13. Baeuerle, P.A., and D. Baltimore. 1988. Activation of DNA-binding activity in an apparently cytoplasmic precursors of the NF-κB transcription factor. Cell. 53:211-217.
14. Kopp, E.B., and S. Ghosh. 1995. NF-κB and Rel proteins in innate immunity. Adv. Immunol. 58:1-27.
15. Valone, F.H., and L.B. Epstein. 1988. Biphasic platelet-activating factor synthesis by human monocytes stimulated with IL-1β, tumor necrosis factor, or IFN-γ. J. Immunol. 141: 3945-3950.
16. Bussolino, F., G. Camussi, and C. Baglioni. 1988. Synthesis and release of platelet-activating factor by human vascular endothelial cells treated with tumor necrosis factor or interleukin-1α. J. Biol. Chem. 263:11856-11861.
17. Park, J.S., I.H. Choi, D.G. Lee, S.S. Han, T.Y. Ha, H.H. Lee, W.H. Lee, Y.M. Park, and H.K. Lee. 1997. Anti-IL-4 monoclonal antibody prevents antibiotics-induced active fatal anaphylaxis. J. Immunol. 158:5002-5006.
18. Choi, I.H., Y.M. Shin, J.S. Park, M.S. Lee, E.H. Han, O.H. Chai, S.Y. Im, T.Y. Ha, and H.K. Lee. 1998. Immunoglobulin E-dependent active fatal anaphylaxis in mast cell-deficient mice. J. Exp. Med. 188:1587-1592.
19. Suk, K., S. Kim, T.H. Kim, K.A. Kim, I. Chang, H. Yagita, M. Shong, and M.S. Lee. 2001. IFN-γ/TNF-α synergism as the final effector in autoimmune diabetes: a key role for STAT1/IFN regulatory factor-1 pathway in pancreatic beta cell death. J. Immunol. 166:4481-4489.
20. Bowdre, J.H., M.D. Poole, and J.D. Oliver. 1981. Edema and hemoconcentration in mice experimentally infected with Vibrio vulnificus. Infect. Immun. 32:1193-1199.
21. Han, S.J., H.M. Ko, J.H. Choi, K.H. Seo, H.S. Lee, E.K. Choi, I.W. Choi, H.K. Lee, and S.Y. Im. 2002. Molecular mechanisms for lipopolysaccharide-induced biphasic activation of nuclear factor-κB (NF-κB). J. Biol. Chem. 277: 44715-44721.
22. Pasparakis, M., L. Alexopoulou, V. Episkopou, and G. Kollias. 1996. Immune and inflammatory responses in TNF-α-deficient mice: a critical requirement for TNF-α in the formation of primary B cell follicles, follicular dendritic cell networks, and germinal centers, and in the maturation of the humoral immune response. J. Exp. Med. 184:1397-1411.
23. Dinarello, C.A. 1991. Interleukin-1 and interleukin-1 antagonism. Blood. 77:1627-1652.
24. Dinarello, C.A. 1996. Biologic basis for interleukin-1 in disease. Blood. 87:2095-2147.
25. Galli, S.J., Wershil, B.K., Gordon, J.R, and Martin, T.R. 1989. Mast cells: immunologically specific effectors and potential sources of multiple cytokines during IgE-dependent responses. Ciba. Found. Symp. 147:53-65; discussion 65-73.
26. Buttke, T.M., and P.A. Sandstrom. 1995. Redox regulation of programmed cell death in lymphocytes. Free Radic. Res. 22:389-397.
27. Fukuda, A.I., and K.F. Breuel. 1996. Effect of platelet activating factor on embryonic development and implantation in the mouse. Hum. Reprod. 11:2746-2749.
28. Gay, J.C. 1993. Mechanism and regulation of neutrophil priming by platelet-activating factor. J. Cell. Physiol. 156: 189-197.
29. Ko, H.M., K.H. Seo, S.J. Han, K.Y. Ahn, I.H. Choi, G.Y. Koh, H.K. Lee, M.S. Ra, and S.Y. Im. 2002. NF-κB-dependency of platelet-activating factor-induced angiogenesis. Cancer Res. 62:1809-1814.
30. Wershil, B.K., Z.S. Wang, J.R. Gordon, and S.J. Galli. 1991. Recruitment of neutrophils during IgE-dependent cutaneous late phase reactions in the mouse is mast cell-dependent. Partial inhibition of the reaction with antiserum against tumor necrosis factor. J. Clin. Invest. 87:446-453.
31. Im, S.Y., H.M. Ko, J.W. Kim, H.K. Lee, T.Y. Ha, H.B. Lee, S.J. Oh, S. Bai, K.C. Chung, Y.B. Lee, et al. 1996. Augmentation of tumor metastasis by platelet-activating factor. Cancer Res. 56:2662-2665.
32. Montrucchio, G., E. Lupia, E. Battaglia, G. Passerini, F. Bussolino, G. Emanuelli, and G. Camussi. 1994. Tumor necrosis factor α-induced angiogenesis depends on in situ platelet-activating factor biosynthesis. J. Exp. Med. 180:377-382.
33. Nourshargh, S., S.W. Larkin, A. Das, and T.J. Williams. 1995. Interleukin-1-induced leukocyte extravasation across rat mesenteric microvessels is mediated by platelet-activating factor. Blood. 85:2553-2558.
34. 2 activity and gene expression are stimulated by tumor necrosis factor: dexamethasone blocks the induced synthesis. Proc. Natl. Acad. Sci. USA. 90:4475-4479.
35. 2. J. Biol. Chem. 272:16709-16712.
36. Samuelsson, B., S.E. Dahlen, J.A. Lindgren, C.A. Rouzer, and C.N. Serhan. 1987. Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science. 237:1171-1176.
37. Irvine, R.F. 1982. How is the level of free arachidonic acid controlled in mammalian cells? Biochem. J. 204:3-16.
38. d genotypes. Exp. Cell Biol. 55:63-68.